Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$307,109
-$590,400 QoQ
Shares Held
7,199
-55.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#411
of 712 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bayesian Capital Management, LP holds $5,153,335 across 7 Drug Manufacturers - General names. SNY ranks #7 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
9,100 | $1,149,694 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
19,200 | $1,106,304 | |
| 3 | GSK |
GSK plc
|
18,100 | $948,802 | |
| 4 | AMGN |
Amgen Inc
|
2,384 | $863,294 | |
| 5 | NVO |
Novo Nordisk A S
|
8,500 | $407,490 | |
| 6 | NVS |
Novartis AG
|
2,365 | $370,642 | |
| 7 | SNY |
Sanofi
This page
|
7,199 | $307,109 |
All Filings in SNY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $307,109 | 7,199 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $897,509 | 16,183 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,875,327 | 38,883 | Shares | Sole | 2025-02-14 | |
| 2022-06-30 | $274,614 | 5,489 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,771,795 | 53,989 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $592,332 | 11,823 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $827,910 | 17,173 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $250,960 | 5,074 | Shares | Sole | 2021-05-14 | |
| 2020-03-31 | $554,500 | 12,683 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||